Astria Therapeutics (ATXS) SEC Filings & 10K Form

$9.54
+0.11 (+1.17%)
(As of 05/17/2024 08:53 PM ET)

Recent Astria Therapeutics SEC Filings

DateFilerForm TypeView
04/22/2024
3:06 PM
Astria Therapeutics (Filer)
Form DEF 14A
04/22/2024
3:08 PM
Astria Therapeutics (Filer)
Form DEFA14A
04/22/2024
3:10 PM
Astria Therapeutics (Filer)
Form ARS
04/09/2024
7:07 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/09/2024
7:09 AM
AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
Form 3
Initial statement of beneficial ownership of securities  
04/09/2024
7:11 AM
AGARWAL SUNIL (Reporting)
Astria Therapeutics (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
03/25/2024
6:37 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
03/11/2024
7:19 AM
Astria Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
03/07/2024
11:29 AM
Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G/A
02/14/2024
2:48 PM
Astria Therapeutics (Subject)
Fairmount Funds Management LLC (Filed by)
Form SC 13G/A
02/14/2024
7:36 AM
Astria Therapeutics (Subject)
Deep Track Capital, LP (Filed by)
Form SC 13G/A
02/09/2024
7:35 AM
Astria Therapeutics (Subject)
FMR LLC (Filed by)
Form SC 13G/A
01/31/2024
7:59 AM
Astria Therapeutics (Filer)
Form 424B5
01/31/2024
8:00 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/30/2024
4:03 PM
Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
01/30/2024
5:01 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/29/2024
4:26 PM
Astria Therapeutics (Subject)
BlackRock Inc. (Filed by)
Form SC 13G
01/29/2024
3:39 PM
Astria Therapeutics (Subject)
Morabito Christopher (Reporting)
Form 144
Notice of proposed sale of securities pursuant to Rule 144  
01/05/2024
7:30 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/02/2024
3:16 PM
Astria Therapeutics (Subject)
Venrock Healthcare Capital Partners III, L.P. (Filed by)
Form SC 13G
01/01/2024
11:15 PM
Astria Therapeutics (Filer)
Form EFFECT
12/28/2023
1:09 PM
Astria Therapeutics (Filer)
Form S-3/A
12/22/2023
1:51 PM
Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/20/2023
3:30 PM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
12/15/2023
7:30 AM
Astria Therapeutics (Filer)
Form S-3
Registration statement under Securities Act of 1933  
11/13/2023
7:06 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/18/2023
3:11 PM
Astria Therapeutics (Subject)
PERCEPTIVE ADVISORS LLC (Filed by)
Form SC 13D/A
10/18/2023
3:11 PM
Astria Therapeutics (Issuer)
EDELMAN JOSEPH (Reporting)
PERCEPTIVE ADVISORS LLC (Reporting)
PERCEPTIVE LIFE SCIENCES MASTER FUND LTD (Reporting)
Perceptive Xontogeny Venture Fund, LP (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/12/2023
4:01 PM
Astria Therapeutics (Filer)
Form 424B5
10/12/2023
4:04 PM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/12/2023
7:00 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/11/2023
6:24 PM
Astria Therapeutics (Subject)
Form FWP
10/11/2023
4:14 PM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:00 AM
Astria Therapeutics (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/06/2023
7:00 AM
Astria Therapeutics (Issuer)
BATE KENNETH (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:02 AM
Astria Therapeutics (Issuer)
Beck Joanne T. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:03 AM
Astria Therapeutics (Issuer)
Clauser Noah (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:04 AM
Astria Therapeutics (Issuer)
Morabito Christopher (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:04 AM
Astria Therapeutics (Issuer)
Callori Fred (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:05 AM
Astria Therapeutics (Issuer)
Cole Hugh M (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:06 AM
Astria Therapeutics (Issuer)
Violin Jonathan (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
Crypto Pioneer Says: “The last crypto bull market has begun.” (Ad)

Right now, there’s over $6 trillion in potential investment money waiting on the sidelines. That means this crypto bull market has a lot more room to run before it comes close to being a bubble.

Click here if you’d like to learn more about these five cryptos…
06/06/2023
7:06 AM
Astria Therapeutics (Issuer)
LAPOINTE ANTHONY GREGG (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:06 AM
Astria Therapeutics (Issuer)
KISHBAUCH MICHAEL D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:07 AM
Astria Therapeutics (Issuer)
Harshbarger Benjamin (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:07 AM
Astria Therapeutics (Issuer)
Komjathy Andrew (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:08 AM
Astria Therapeutics (Issuer)
Matthews Andrea (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2023
7:08 AM
Astria Therapeutics (Issuer)
Milne Jill C. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/23/2023
11:15 PM
Astria Therapeutics (Filer)
Form EFFECT
(Data available from 1/1/2016 forward)


Related Companies and Tools

This page (NASDAQ:ATXS) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners